Prognostic performance of early immune and endothelial activation markers in mild-to-moderate COVID-19 outpatients: a nested case-control study.
Saved in:
| Title: | Prognostic performance of early immune and endothelial activation markers in mild-to-moderate COVID-19 outpatients: a nested case-control study. |
|---|---|
| Authors: | Alemany A; ISGlobal, Barcelona, Spain.; Fight Infectious Diseases Foundation, Badalona, Spain.; Hospital Universitari Germans Trias i Pujol, Badalona, Spain., Balanza N; ISGlobal, Barcelona, Spain.; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona (UB), Barcelona, Spain., Millat-Martinez P; ISGlobal, Barcelona, Spain., Ouchi D; ISGlobal, Barcelona, Spain.; Fight Infectious Diseases Foundation, Badalona, Spain., Corbacho-Monné M; Fight Infectious Diseases Foundation, Badalona, Spain.; Hospital Universitari Germans Trias i Pujol, Badalona, Spain.; Hospital Universitari Parc Taulí, Sabadell, Spain., Morales-Indiano C; Hospital Universitari Germans Trias i Pujol, Badalona, Spain.; Clinical Laboratory Metropolitana Nord, Badalona, Spain., Fernández Rivas G; Microbiology Department, Clinical Laboratory Metropolitana Nord, Barcelona, Spain., Blanco I; Hospital Universitari Germans Trias i Pujol, Badalona, Spain.; Clinical Laboratory Metropolitana Nord, Badalona, Spain., Mitjà O; Fight Infectious Diseases Foundation, Badalona, Spain.; Hospital Universitari Germans Trias i Pujol, Badalona, Spain., Aguilar R; ISGlobal, Barcelona, Spain.; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona (UB), Barcelona, Spain.; CIBER Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain., Dobaño C; ISGlobal, Barcelona, Spain.; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona (UB), Barcelona, Spain.; CIBER Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain., Bassat Q; ISGlobal, Barcelona, Spain.; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona (UB), Barcelona, Spain.; CIBER de Epidemiología y Salud Pública, Instituto de Salud Carlos III, Madrid, Spain.; Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.; ICREA, Pg Lluís Companys 23, Barcelona, Spain.; Pediatrics Department, Hospital Sant Joan de Déu, Universitat de Barcelona, Esplugues, Barcelona, Spain.; Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique., Moncunill G; ISGlobal, Barcelona, Spain.; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona (UB), Barcelona, Spain.; CIBER Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain., Baro B; ISGlobal, Barcelona, Spain. |
| Corporate Authors: | COnV-ert BMK STUDY GROUP |
| Source: | Frontiers in immunology [Front Immunol] 2024 Nov 27; Vol. 15, pp. 1501872. Date of Electronic Publication: 2024 Nov 27 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39664394 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Prognostic performance of early immune and endothelial activation markers in mild-to-moderate COVID-19 outpatients: a nested case-control study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Alemany+A%22">Alemany A</searchLink>; ISGlobal, Barcelona, Spain.; Fight Infectious Diseases Foundation, Badalona, Spain.; Hospital Universitari Germans Trias i Pujol, Badalona, Spain.<br /><searchLink fieldCode="AU" term="%22Balanza+N%22">Balanza N</searchLink>; ISGlobal, Barcelona, Spain.; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona (UB), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Millat-Martinez+P%22">Millat-Martinez P</searchLink>; ISGlobal, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Ouchi+D%22">Ouchi D</searchLink>; ISGlobal, Barcelona, Spain.; Fight Infectious Diseases Foundation, Badalona, Spain.<br /><searchLink fieldCode="AU" term="%22Corbacho-Monné+M%22">Corbacho-Monné M</searchLink>; Fight Infectious Diseases Foundation, Badalona, Spain.; Hospital Universitari Germans Trias i Pujol, Badalona, Spain.; Hospital Universitari Parc Taulí, Sabadell, Spain.<br /><searchLink fieldCode="AU" term="%22Morales-Indiano+C%22">Morales-Indiano C</searchLink>; Hospital Universitari Germans Trias i Pujol, Badalona, Spain.; Clinical Laboratory Metropolitana Nord, Badalona, Spain.<br /><searchLink fieldCode="AU" term="%22Fernández+Rivas+G%22">Fernández Rivas G</searchLink>; Microbiology Department, Clinical Laboratory Metropolitana Nord, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Blanco+I%22">Blanco I</searchLink>; Hospital Universitari Germans Trias i Pujol, Badalona, Spain.; Clinical Laboratory Metropolitana Nord, Badalona, Spain.<br /><searchLink fieldCode="AU" term="%22Mitjà+O%22">Mitjà O</searchLink>; Fight Infectious Diseases Foundation, Badalona, Spain.; Hospital Universitari Germans Trias i Pujol, Badalona, Spain.<br /><searchLink fieldCode="AU" term="%22Aguilar+R%22">Aguilar R</searchLink>; ISGlobal, Barcelona, Spain.; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona (UB), Barcelona, Spain.; CIBER Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Dobaño+C%22">Dobaño C</searchLink>; ISGlobal, Barcelona, Spain.; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona (UB), Barcelona, Spain.; CIBER Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Bassat+Q%22">Bassat Q</searchLink>; ISGlobal, Barcelona, Spain.; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona (UB), Barcelona, Spain.; CIBER de Epidemiología y Salud Pública, Instituto de Salud Carlos III, Madrid, Spain.; Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.; ICREA, Pg Lluís Companys 23, Barcelona, Spain.; Pediatrics Department, Hospital Sant Joan de Déu, Universitat de Barcelona, Esplugues, Barcelona, Spain.; Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique.<br /><searchLink fieldCode="AU" term="%22Moncunill+G%22">Moncunill G</searchLink>; ISGlobal, Barcelona, Spain.; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona (UB), Barcelona, Spain.; CIBER Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Baro+B%22">Baro B</searchLink>; ISGlobal, Barcelona, Spain. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22COnV-ert+BMK+STUDY+GROUP%22">COnV-ert BMK STUDY GROUP</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2024 Nov 27; Vol. 15, pp. 1501872. <i>Date of Electronic Publication: </i>2024 Nov 27 (<i>Print Publication: </i>2024). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39664394 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fimmu.2024.1501872 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1501872 Titles: – TitleFull: Prognostic performance of early immune and endothelial activation markers in mild-to-moderate COVID-19 outpatients: a nested case-control study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Alemany A – PersonEntity: Name: NameFull: Balanza N – PersonEntity: Name: NameFull: Millat-Martinez P – PersonEntity: Name: NameFull: Ouchi D – PersonEntity: Name: NameFull: Corbacho-Monné M – PersonEntity: Name: NameFull: Morales-Indiano C – PersonEntity: Name: NameFull: Fernández Rivas G – PersonEntity: Name: NameFull: Blanco I – PersonEntity: Name: NameFull: Mitjà O – PersonEntity: Name: NameFull: Aguilar R – PersonEntity: Name: NameFull: Dobaño C – PersonEntity: Name: NameFull: Bassat Q – PersonEntity: Name: NameFull: Moncunill G – PersonEntity: Name: NameFull: Baro B IsPartOfRelationships: – BibEntity: Dates: – D: 27 M: 11 Text: 2024 Nov 27 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1664-3224 Numbering: – Type: volume Value: 15 Titles: – TitleFull: Frontiers in immunology Type: main |
| ResultId | 1 |